Search results:
Search results from www.aesgp.eu
Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
---|---|---|---|---|---|---|
Paracetamol | N Nervous system. Nervous system | N02. Analgesics | 1955 | USA | OTC | — |
Dextromethorphan | R Respiratory system. Respiratory system | R05. Cough and cold preparations | 1958 | USA | OTC | Adult dose 10-20 mg every 4 hours or 30 mg every 6 hours; 120 mg daily maximum |
Pseudoephedrine | R Respiratory system. Respiratory system | R01. Nasal preparations | 1976 | USA | OTC | Pseudoephedrine hydrochloride or sulphate. Oral form. Adult dosage is 60mg/4 or 4-6 hours. For hydrochloride, maximum dose is 240mg/24 hours. |
Chlorpheniramine (Chlorphenamine) | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1976 | USA | OTC | Chlorpheniramine maleate. Oral form. Adult dosage is 4mg/4-6 hours. In 1981, it received OTC approval for oral time-released form with adult dosage of 12mg/12 hours. |
Brompheniramine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1976 | USA | OTC | Brompheniramine maleate. Oral form. Adult dosage is 4mg /4-6 hours. |
Dexchlorpheniramine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1976 | USA | OTC | In 1992, dexchlorpheniramine maleate received OTC approval as antihistamine with an adult dosage of 2mg / 4-6 hours (oral). |
Oxymetazoline | R Respiratory system. Respiratory system | R01. Nasal preparations | 1976 | USA | OTC | Oxymetazoline hydrochloride. Topical nasal decongestant as 0.05% in aqueous solution. In 1986, oxymetazoline HCl was approved OTC as ocular vasoconstrictor with a dosage of 0.025% solution/drops (topical). |
Xylometazoline (nasal) | R Respiratory system. Respiratory system | R01. Nasal preparations | 1976 | USA | OTC | Xylometazoline hydrochloride as topical nasal decongestant with adult dosage as 0.01% in aqueous solution. |
Doxylamine succinate | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1978 | USA | OTC | Oral form. Adult dosage is 25mg single dose only (sleep-aid). |
Hydrocortisone (topical) | D Dermatologicals. Dermatologicals | D07. Corticosteroids, dermatological preparations | 1979 | USA | OTC | Hydrocortisone or hydrocortisone acetate as antipruritic. Dosages from 0.25 to 0.50%. In 1991, OTC approval for dosages between 0.5% and 1%. |
Phenylephrine | R Respiratory system. Respiratory system | R01. Nasal preparations | 1980 | USA | OTC | Nasal decongestant. 10 mg. 1980: Phenylephrine hydrochloride as topical anorectal / vasoconstrictor. Dosage is 0.25%. From 2010, ibuprofen and phenylephrine hydrochloride (200mg ibuprofen + 10mg phenylephrine HCl) is OTC as an analgesic/decongestant. |
Ephedrine | R Respiratory system. Respiratory system | R01. Nasal preparations | 1980 | USA | OTC | Ephedrine sulfate as topical anorectal. Dosage is 0.1 to 1.25%. Oral as a bronchodilator. |
Diphenhydramine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1981 | USA | OTC | Diphenhydramine hydrochloride as antitussive. Oral form. Adult dosage is 25mg/4 hours. In 1982, diphenhydramide both hydrochloride and monocitrate received OTC approval as sleep aid with a single oral dose of 50mg and 76mg respectively. In 1985, diphenhydramine hydrochloride received OTC approval as antihistamine with an adult dosage of 25-50mg / 4-6 hours (oral). In 1987, it received OTC approval with the same dosage but as antiemetic. |
Dexbrompheniramine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1982 | USA | OTC | Dexbrompheniramine maleate as antihistamine. Adult dosage is 6mg/12 hours (oral time-released). In 1985, it received OTC approval with an adult dosage of 2mg/4-6 hours (oral). In 1987, it received OTC approval with an adult dosage of 3mg/6-8 hours (oral). |
Trip(r)olidine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1982 | USA | OTC | Triprolidine hydrochloride as antihistamine. Adult dosage is 2.5mg/4-6 hours. In 1985, triprolidine HCl was approved OTC with a dosage of 5mg / 12 hours. |
Miconazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1982 | USA | OTC | Miconazole nitrate as anticandidal, 4% cream. Three-day vaginal yeast infection treatment switched in 1996. |
Haloprogin (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1982 | USA | OTC | Dosage is 1% as topical antifungal. |
Dyclonine (oral) | N Nervous system. Nervous system | N01. Anesthetics | 1982 | USA | OTC | Dyclonine hydrochloride as oral anaesthetic. Adult dosage is 0.05 to 0.1% in rinse, mouthwash, gargle or spray, 3-4 times daily. Dosage is 1 to 3mg as lozenge. |
Ibuprofen (oral) | M Musculo-skeletal system. Musculo-skeletal system | M01. Antiinflammatory and antirheumatic products | 1984 | USA | OTC | Ibuprofen as internal analgesic/antipyretic. Adult dosage is 200mg/4-6 hours. Migraine indication added in 2000. In 1995, ibuprofen suspension received OTC approval as internal analgesic/antipyretic with a paediatric dosage of 7.5mg/kg up to 4 times a day. In 2005, an analgesic sleep aid containing a combination of 400mg ibuprofen + 78mg diphenhydramine citrate or 50mg diphenhydramine hydrochloride was switched to non-prescription status. From 2010, ibuprofen and phenylephrine hydrochloride (200mg ibuprofen + 10mg phenylephrine HCl) is OTC as an analgesic/decongestant. |
Pyrantel | P Antiparasitic products, insecticides and repellents. Antiparasitic products, insecticides and repellents | P02. Anthelmintics | 1986 | USA | OTC | Pyrantel embonate. |
Chlorphendianol | R Respiratory system. Respiratory system | R05. Cough and cold preparations | 1987 | USA | OTC | Chlorphendianol HCl as antitussive. Adult dosage is 25mg / 6-8 hours (oral). |
Loperamide | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | 1988 | USA | OTC | Antidiarrhoeal. Dosage for adults and children 12 and over is 4mg, then 2mg, up to 8mg/day (oral). Children 9-11: 2 mg, up to 6 mg/day. Children 6-8: 2 mg, up to 4 mg/daily |
Acetylsalicylic acid | N Nervous system. Nervous system | N02. Analgesics | 1988 | USA | OTC | — |
Clotrimazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1989 | USA | OTC | Separate applications for antifungal for athlete's foot or jock itch, and as a vaginal antifungal, 1% lotion and cream, twice daily. |
Clotrimazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | 1990 | USA | OTC | Clotrimazole as anticandidal, 1% cream and 200mg inserts. Original approval in 1990. Strength change in 1996. |
Miconazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | 1991 | USA | OTC | Miconazole nitrate as anticandidal, 4% cream. Three-day vaginal yeast infection treatment switched in 1996. |
Clemastine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 1992 | USA | OTC | Clemastine fumarate as antihistamine. Adult dosage is 1.34mg/12 hours. Same dosage when used in combination with phenylpropanolamine HCl as antihistamine / decongestant. |
Naproxen | M Musculo-skeletal system. Musculo-skeletal system | M01. Antiinflammatory and antirheumatic products | 1994 | USA | OTC | Naproxen received OTC approval as internal analgesic / antipyretic with an adult dosage of 200mg / 8-12 hours (oral). |
Ranitidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 1995 | USA | OTC | Heartburn, acid reducer. 150mg dose up to 2 times a day, in adults and adolescents aged 12 and over. |
Ketoprofen | M Musculo-skeletal system. Musculo-skeletal system | M01. Antiinflammatory and antirheumatic products | 1995 | USA | OTC | Ketoprofen as internal analgesic with a dosage of 12.5mg (lower strength than the Rx version) every 4 to 6 hours. |
Butoconazole | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | 1995 | USA | OTC | Butoconazole nitrate as anticandidal, with a dosage of 2.0% cream and applicators. Three-day treatment for vaginal yeast infections (previously seven-day treatment). |
Famotidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 1995 | USA | OTC | Heartburn, acid reducer. Adult dosage of 10mg up to 20mg per day. 12 years of age and older. |
Cimetidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 1995 | USA | OTC | Heartburn, acid reducer. 200mg up to twice a day, in adults and adolescents aged 12 years and over. |
Nicotine (patch) | N Nervous system. Nervous system | N07. Other nervous system drugs | 1996 | USA | OTC | One dose (15mg) patch to be used no longer than six weeks. Also in 21mg, 14mg, and 7mg patch series. |
Nicotine (gum) | N Nervous system. Nervous system | N07. Other nervous system drugs | 1996 | USA | OTC | 2mg & 4mg. |
Nizatidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 1996 | USA | OTC | Acid reducer, 75mg up to twice daily, in adults and adolescents aged 12 and over. |
Minoxidil (topical) | D Dermatologicals. Dermatologicals | D11. Other dermatological preparations | 1996 | USA | OTC | 2% and 5 % topical solution as hair grower. |
Cromoglicic acid | R Respiratory system. Respiratory system | R01. Nasal preparations | 1997 | USA | OTC | Sodium cromoglycate 4% nasal spray for relief and prevention of the nasal symptoms of hay-fever and other nasal allergies in adults and children six years of age and older. |
Ketoconazole (topical) | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1997 | USA | OTC | Shampoo only (1%) to control symptoms of dandruff, psoriasis, and seborrheic dermatitis. |
Tioconazole | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1997 | USA | OTC | Tioconazole as a vaginal ointment. Dosage of 6.5% in one-dose treatment. |
Terbinafine | D Dermatologicals. Dermatologicals | D01. Antifungals for dermatological use | 1999 | USA | OTC | Only OTC for topical preparations (1%). Tablets remain Rx. |
Docosanol (topical) | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | 2000 | USA | OTC | 10% cream for cold sore / fever blister. |
Loratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2002 | USA | OTC | 10mg/day tablets or syrup antihistamine for hives relief. |
Nicotine (sublingual) | N Nervous system. Nervous system | N07. Other nervous system drugs | 2002 | USA | OTC | — |
Omeprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 2003 | USA | OTC | Omeprazole 20mg/day acid reducer to treat frequent heartburn. 20mg Omeprazole and 1100mg Sodium bicarbonate to treat frequent heartburn switched to non-prescription status in December 2009. |
Macrogol (Polyethylene glycol 3350) | A Alimentary tract and metabolism. Alimentary tract and metabolism | A06. Laxatives | 2006 | USA | OTC | Osmotic laxative. 17g powder stirred into a beverage, in adults and adolescents aged 17 and over. |
Levonorgestrel | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | 2006 | USA | OTC | Levornorgestrel 2x0.75mg tablets switched to OTC status for emergency contraception for women over 18 years in August 2006 following a protracted and highly publicised approval process spanning several years. In April 2009 the product became available for women 17 years and over. In July 2009, levonorgestrel 1.5mg switched to OTC status. |
Ketotifen | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2006 | USA | OTC | Ketotifen 0.025% ophthalmic solution switched to non-prescription status in 2006. |
Cetirizine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2007 | USA | OTC | 5mg and 10mg tablets and chewable tablets, and 1mg/ml (children's syrup) for the temporary relief of symptoms due to hayfever or other respiratory allergies (sneezing, runny nose, itchy or watery eyes, itchy throat or nose). Extended-release tablets containing 5mg cetirizine HCl and 120mg pseudoephedrine HCl for the relief of symptoms due to hayfever or other upper respiratory allergies. |
Orlistat | A Alimentary tract and metabolism. Alimentary tract and metabolism | A08. Antiobesity preparations | 2007 | USA | OTC | Orlistat 60 mg capsules up to 3 times per day as a weight loss aid for overweight adults. |
- Page 1 of 6
- Next
- 50 of 264 ingredients